Scientist/Senior Scientist, Assay Development - Neuroscience Biomarkers

The role

The Scientist/Senior Scientist will develop a portfolio of ultrasensitive immunoassays throughout the product lifecycle. This role involves designing assay-development studies, translating biomarker biology into design strategies, and analyzing clinical and preclinical sample data.

What you will do

• Develop a portfolio of ultrasensitive immunoassays from screening through transfer.
• Plan, design, and execute hands-on assay-development studies.
• Provide scientific leadership by translating biomarker biology into assay-design strategies.
• Analyze data from clinical and preclinical samples.
• Collaborate with Platform, Product Development, Operations, and Business Development teams.
• Prepare scientific presentations, technical reports, study summaries, abstracts, and publications.
• Contribute to a collaborative startup environment.

Required qualifications

• Ph.D. in Neuroscience, Neurobiology, Molecular Biology, Biochemistry, Biomedical Engineering, or a closely related field.
• Strong scientific expertise in fluid biomarkers and assay-development strategies for neurodegenerative diseases.
• Strong understanding of biomarker heterogeneity and factors influencing measurement in human biofluids.
• Hands-on experience developing immunoassays or other quantitative protein-detection methods.
• Demonstrated ability to design experiments independently and troubleshoot technical challenges.
• Evidence of meaningful scientific contributions through peer-reviewed publications, patents, conference presentations, or translational research programs.
• Strong written and verbal communication skills.
• Experience working in a startup or fast-paced biotechnology environment.
• A record of rapidly increasing scientific ownership, leadership, or responsibility.
• Can work 5 days/week on site in Woburn, MA.

Benefits

• Competitive compensation
• Meaningful stock ownership
• Comprehensive benefits

About the company

Spear Bio is a well-funded and rapidly growing biotech start-up headquartered in Woburn, Massachusetts. The company uses proprietary Successive Proximity Extension Amplification Reaction (SPEAR) technology to provide ultrasensitive solutions for measuring low-abundant biomarkers.